You are here: Industry Insights > ezetimibe

News List

Sandoz issues voluntary recall for medication bottles europeanpharmaceuticalreview
September 04, 2019
The pharmaceutical company has announced a recall for certain prescription drug bottles which do not meet child-resistant regulations.
Daiichi Sankyo Reports Positive Initial Results from Bempedoic Acid / Ezetimibe Study americanpharmaceuticalreview
September 03, 2019
Daiichi Sankyo Europe GMbH announced positive initial results from the 12-week Phase 2 bempedoic acid / ezetimibe fixed dose combination (FDC) tablet study (also known as Study 058).
Sandoz Recalls Losartan Potassium, Ezetimibe Prescription Bottles americanpharmaceuticalreview
September 03, 2019
Sandoz has voluntarily recalled losartan potassium and ezetimibe in prescription drug bottles in the U.S. due to failure to meet child-resistant closure requirements.
Esperion’s Bempedoic Acid/ Ezetimibe Tablet Achieves Positive Phase II Results contractpharma
August 30, 2019
Treatment developed to lower elevated LDL-C levels in patients with hypercholesterolemia and type 2 diabetes.
Esperion Announces U.S. FDA Acceptance of New Drug Applications (NDAs) for Both Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet for Filing and Regulatory Review drugs
May 17, 2019
Esperion Announces U.S. FDA Acceptance of New Drug Applications (NDAs) for Both Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet for Filing and Regulatory Review.
Praluent not worth the price, finds study pharmaphorum
January 04, 2019
Sanofi and Regeneron’s Praluent may still not be cost effective compared to other cholesterol-lowering drugs despite a recent price cut, a new study has claimed.....